Cell-mediated and direct gene therapy for bone regeneration

Expert Opinion on Biological Therapy

Volumn 12, Issue 4, 2012, Pages 411-423

  Ishihara, Akikazu ^a   Bertone, Alicia L ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Bone morphogenetic protein; Bone regeneration; Gene therapy; Stem cells

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; FIBROBLAST GROWTH FACTOR 2; OSTEOGENIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; TRANSCRIPTION FACTOR RUNX2;

ADENOVIRUS; ADIPOSE DERIVED STEM CELL; BLOOD CELL; BONE MARROW; BONE REGENERATION; CALLUS; CELL BASED GENE THERAPY; CELL TRANSPLANTATION; DNA MODIFICATION; ELECTROPORATION; EMBRYONIC STEM CELL; EX VIVO GENE TRANSFER; FRACTURE NONUNION; GENE EXPRESSION; HUMAN; IN VIVO GENE TRANSFER; LENTIVIRINAE; NONHUMAN; PLURIPOTENT STEM CELL; RETROVIRUS; REVIEW; SKIN CULTURE; TISSUE REGENERATION;

ANIMALS; BONE DISEASES; BONE REGENERATION; GENE THERAPY; GENETIC VECTORS; HUMANS; OSTEOGENESIS;

ANIMALIA;

EID: 84858690327     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2012.661709     Document Type: Review

References (98)

1. Tzioupis C, Giannoudis PV. Prevalence of long-bone non-unions. Injury 2007;38(Suppl 2):S3-9 (Pubitemid 47498401)
2. Reichert JC, Saifzadeh S, Wullschleger ME, et al. The challenge of establishing preclinical models for segmental bone defect research. Biomaterials 2009;30:2149-63
3. Finkemeier CG. Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am 2002;84-A:454-64 (Pubitemid 37107720)
4. Brand RA. Advances in limb lengthening and reconstruction: alessandro Codivilla, MD, 1861 - 1912. Clin Orthop Relat Res 2008;466:2901-2
5. Kloen P, Di Paola M, Borens O, et al. BMP signaling components are expressed in human fracture callus. Bone 2003;33:362-71 (Pubitemid 37103253)
6. Murnaghan M, McIlmurray L, Mushipe MT, Li G. Time for treating bone fracture using rhBMP-2: a randomized placebo controlled mouse fracture trial. J Orthop Res 2005;23:625-31 (Pubitemid 40631335)
7. Han DK, Kim CS, Jung UW, et al. Effect of a fibrin-fibronectin sealing system as a carrier for recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects. J Periodontol 2005;76:221:6-22
8. Friedlaender GE. Osteogenic protein-1 in treatment of tibial nonunions: current status. Surg Technol Int 2004;13:249-52
9. Liu Y. Overexpressed LIM mineralization proteins do not require LIM domains to induce bone. J Bone Miner Res 2002;17:406-14 (Pubitemid 34171755)
10. Yu Y, Mu J, Fan Z, et al. Insulin-like growth factor 1 enhances the proliferation and osteogenic differentiation of human periodontal ligament stem cells via ERK and JNK MAPK pathways. Histochem Cell Biol 2012;published online 7 January 2012; doi:10.1007/s00418-011-0908-
11. Fei Y, Xiao L, Doetschman T, et al. Fibroblast growth factor 2 stimulation of osteoblast differentiation and bone formation is mediated by modulation of the Wnt signaling pathway. J Biol Chem 2011;286:40575-83
12. Caplan AI, Correa D. PDGF in bone formation and regeneration: new insights into a novel mechanism involving MSCs. Orthop Res 2011;29:1795-803
13. Liu B, Li X, Liang G, Liu X. VEGF expression in mesenchymal stem cells promotes bone formation of tissue-engineered bones. Mol Med Rep 2011;4:1121-6
14. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004;22:233-41 (Pubitemid 40136452)
15. Abe E, Yamamoto M, Taguchi Y, et al. Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin. J Bone Miner Res 2000;15:663-73 (Pubitemid 30174020)
16. Yang L, Zhang Y, Dong R, et al. Effects of adenoviral-mediated coexpression of bone morphogenetic protein-7 and insulin-like growth factor-1 on human periodontal ligament cells. J Periodontal Res 2010;45:532-40
17. Rider DA, Dombrowski C, Sawyer AA, et al. Autocrine fibroblast growth factor 2 increases the multipotentiality of human adipose-derived mesenchymal stem cells. Stem Cells 2008;26:1598-608
18. Minamide A, Boden SD, Viggeswarapu M, et al. Mechanism of bone formation with gene transfer of the cDNA encoding for the intracellular protein LMP-1. J Bone Joint Surg 2003;85A:1030-9 (Pubitemid 36644783)
19. Evans CH. Gene therapy for the regeneration of bone. Injury 2011;42:599-604
20. Baltzer AW, Lattermann C, Whalen JD, et al. Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther 2000;11:734-9 (Pubitemid 30255754)
21. Betz OB, Betz VM, Nazarian A, et al. Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects. Ge.ne Ther 2007;14:1039-44 (Pubitemid 46965273)
22. Egermann M, Baltzer AW, Adamaszek S, et al. Direct adenoviral transfer of bone morphogenetic protein-2 cDNA enhances fracture healing in osteoporotic sheep. Hum Gene Ther 2006;17:507-17 (Pubitemid 43794490)
23. Southwood LL, Frisbie SS, Kawcak CE, et al. Evaluation of Ad-BMP-2 for enhancing fracture healing in an infected defect fracture rabbit model. J Orthop Res 2004;22:66-72 (Pubitemid 38035447)
24. Chen Y, Luk KD, Cheung KM, et al. Combination of adeno-associated virus and adenovirus vectors expressing bone morphogenetic protein-2 produces enhanced osteogenic activity in immunocompetent rats. Biochem Biophys Res Commun 2004;317:675-81 (Pubitemid 38481425)
25. Gafni Y, Pelled G, Zilberman Y, et al.Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system. Mol Ther 2004;9:587-95 (Pubitemid 38578809)
26. Bertone AL, Pittman DD, Bouxsein ML, et al. Adenoviral-mediated transfer of human BMP-6 gene accelerates healing in a rabbit ulnar osteotomy mmodel. J Orthop Res 2004;22:1261-70 (Pubitemid 39317917)
27. Laurent JJ, Webb KM, Beres EJ, et al. The use of bone morphogenetic protein-6 gene therapy for percutaneous spinal fusion in rabbits. J Neurosurg Spine 2004;1:90-4 (Pubitemid 38812663)
28. Strohbach CA, Rundle CH, Wergedal JE, et al. LMP-1 retroviral gene therapy influences osteoblast differentiation and fracture repair: a preliminary study. Calcif Tissue Int 2008;83:202-11
29. Kawai M, Bessho K, Maruyama H, et al. Human BMP-2 gene transfer using transcutaneous in vivo electroporation induced both intramembranous and endochondral ossification. Anat Rec A Discov Mol Cell Evol Boiol 2005;287:1264-71 (Pubitemid 43010437)
30. Endo M, Kuroda S, Kondo H, et al. Bone regeneration by modified gene-activated matrix: effectiveness in segmental tibial defects in rats. Tissue Eng 2006;12:489-97 (Pubitemid 43673454)
31. Huang YC, Simmons C, Kaigler D, et al. Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4). Gene Ther 2005;12:418-26 (Pubitemid 40394294)
32. Park J, Lutz R, Felszeghy E, et al. The effect on bone regeneration of liposomal vector to deliver BMP-2 gene to bone grafts in peri-implant bon e defects. Biomaterials 2007;28:2772-82 (Pubitemid 46415761)
33. Osawa K, Okubo Y, Nakao K, et al. Osteoinduction by microbubble-enhanced transcutaneous sonoporation of human bone morphogenetic protein-2. J Gene Med 2009;11:633-41
34. Kimelman N, Pelled G, Helm GA, et al. Review: gene- and stem cell-based therapeutics for bone regeneration and repair. Tissue Eng 2007;13:113:5-50 (Pubitemid 46986715)
35. Backstrom KC, Bertone AL, Wisner ER, Weisbrode SE. Response of induced bone defects in horses to collagen matrix containing the human paratahyroid hormone gene. Am J Vet Res 2004;65:1223-32 (Pubitemid 39232596)
36. Turgeman G, Pittman DD, Muller R, et al. Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy. J Gene Med 2001;3:240-51 (Pubitemid 33684772)
37. Tsuda H, Wada T, Yamashita T, Hamada H. Enhanced osteoinduction by mesenchymal stem cells transfected with a fiber-mutant adenoviral rBMP2 gene. J Gene Med 2005;7:1322-34 (Pubitemid 41555438)
38. Tsuda H, Wada T, Ito Y, et al. Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector. Mol Ther 2003;7:354-65 (Pubitemid 36503859)
39. Jiang X, Zhao J, Wang S, et al. Mandibular repair in rats with premineralized silk scaffolds and BMP-2-modified bMSCs. Biomaterials 2009;30:452:2-32
40. Li J, Li Y, Ma S, et al. Enhancement of bone formation by BMP-7 transduced MSCs on biomimetic nanohydroxyapatite/ polyamide composite scaffolds in repair of mandibular defects. J Biomed Mater Res A 2010;95:973-81
41. Shen FH, Visger JM, Balian G, et al. Systemically administered mesenchymal stromal cells transduced with insulin-like growth factor-I localize to a fracture site and potentiate healing. J Orthop Trauma 2002;16:651-9 (Pubitemid 35214856)
42. Granero-Molto F, Myers TJ, Weis JA, et al. Mesenchymal stem cells expressing insulin-like growth factor-I (MSCIGF) promote fracture healing and restore new bone formation in Irs1 knockout mice: analyses of MSCIGF autocrine and paracrine regenerative effects. Stem Cells 2011;29:153:7-48
43. Virk MS, Conduah A, Park SH, et al. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model. Bone 2008;42:921-31
44. Hsu WK, Sugiyama O, Park SH, et al. Lentiviral-mediated BMP-2 gene transfer enhances healing of segmental femoral defects in rats. Bone 2007;40:931-8 (Pubitemid 46386528)
45. Miyazaki M, Sugiyama O, Tow B, et al. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. J Spinal Disord Tech 2008;21:372-9
46. Lian Z, Chuanchang D, Wei L, et al. Enhanced healing of goat femur-defect using BMP7 gene-modified BMSCs and load-bearing tissue-engineered bone. J Orthop Res 2010;28:412-18
47. Peterson B, Zhang J, Iglesias R, et al. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng 2005;11:120-9 (Pubitemid 40515180)
48. Yang M, Ma QJ, Dang GT, et al. In vitro and in vivo induction of bone formation based on ex vivo gene therapy using rat adipose-derived adult stem cells expressing BMP-7. Cytotherapy 2005;7:273-81 (Pubitemid 41051370)
49. Kang Y, Liao WM, Yuan ZH, et al. In vitro and in vivo induction of bone formation based on adeno-associated virus-mediated BMP-7 gene therapy using human adipose-derived mesenchymal stem cells. Acta Pharmacol Sin 2007;28:839-49 (Pubitemid 46817445)
50. Zhang X, Yang M, Lin L, et al. Runx2 overexpression enhances osteoblastic differentiation and mineralization in adipose-derived stem cells in vitro and in vivo. Calcif Tissue Int 2006;79:169-78 (Pubitemid 44440445)
51. Jeon O, Rhie JW, Kwon IK, et al. In vivo bone formation following transplantation of human adipose-derived stromal cells that are not differentianted osteogenically. Tissue Eng Part A 2008;14:1285-94
52. Li H, Dai K, Tang T, et al. Bone regeneration by implantation of adipose-derived stromal cells expressing BMP-2. Biochem Biophys Res Commun 2007;356:836-42 (Pubitemid 46529369)
53. Dragoo JL, Samimi B, Zhu M, et al. Tissue-engineered cartilage and bone using stem cells from human infrapatellar fat pads. J Bone Joint Surg Br 2003;85:740-7 (Pubitemid 36927045)
54. Dragoo JL, Lieberman JR, Lee RS, et al. Tissue-engineered bone from BMP-2-transduced stem cells derived from human fat. Plast Reconstr Surrg 2005;115:1665-73 (Pubitemid 40604737)
55. Miyazaki M, Zuk PA, Zou J, et al. Comparison of human mesenchymal stem cells derived from adipose tissue and bone marrow for ex vivo gene therapy in rat spinal fusion model. Spine (Phila Pa 1976) 2008:33:863-9 (Pubitemid 351533854)
56. Musgrave DS, Pruchnic R, Bosch P, et al. Human skeletal muscle cells in ex vivo gene therapy to deliver bone morphogenetic protein-2. J Bone Joint Surg Br 2002;84:120-7 (Pubitemid 34105637)
57. Lee JY, Musgrave D, Pelinkovic D, et al. Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J Bone Joint Surg Am 2001;83-A:1032-9 (Pubitemid 32662105)
58. Shen HC, Peng H, Usas A, et al. Ex vivo gene therapy-induced endochondral bone formation: comparison of muscle-derived stem cells and different subpopulations of primary muscle-derived cells. Bone 2004;34:982-92 (Pubitemid 38749235)
59. Corsi KA, Pollett JB, Phillippi JA, et al. Osteogenic potential of postnatal skeletal muscle-derived stem cells is influenced by donor sex. J Bone Miner Res 2007;22:1592-602 (Pubitemid 351229329)
60. Peng H, Usas A, Gearhart B, et al. Development of a self-inactivating tet-on retroviral vector expressing bone morphogenetic protein 4 to achieve regulated bone formation. Mol Ther 2004;9:885-94 (Pubitemid 38878134)
61. Peng H, Usas A, Hannallah D, et al. Noggin improves bone healing elicited by muscle stem cells expressing inducible BMP4. Mol Ther 2005;12:239-46 (Pubitemid 41025093)
62. Peng H, Usas A, Olshanski A, et al. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation iof angiogenesis. J Bone Miner Res 2005;20:2017-27 (Pubitemid 41532787)
63. Hirata K, Tsukazaki T, Kadowaki A, et al. Transplantation of skin fibroblasts expressing BMP-2 promotes bone repair more effectively than those expressing Runx2. Bone 2003;32:502-12 (Pubitemid 39665709)
64. Ishihara A, Zekas LJ, Litsky AS, et al. Dermal fibroblast-mediated BMP2 therapy to accelerate bone healing in an equine osteotomy model. J Orthop Res 2010;28:403-11
65. Ishihara A, Zekas LJ, Weisbrode SE, Bertone AL. Comparative efficacy of dermal fibroblast-mediated and direct adenoviral bone morphogenetic protein-2 gene therapy for bone regeneration in an equine rib model. Gene Ther 2010;17:733-44
66. Wang R, Zou Y, Yuan Z, et al. Autografts and xenografts of skin fibroblasts delivering BMP-2 effectively promote orthotopic and ectopic osteogenesis. Anat Rec (Hoboken) 2009;292:777-86
67. Nussenbaum B, Rutherford RB, Krebsbach PH. Bone regeneration in cranial defects previously treated with radiation. Laryngoscope 2005;115:1170-7 (Pubitemid 40962351)
68. Lattanzi W, Parrilla C, Fetoni A, et al. Ex vivo-transduced autologous skin fibroblasts expressing human Lim mineralization protein-3 efficiently form new bone in animal models. Gene Ther 2008;15:1330-43
69. Gugala Z, Olmsted-Davis EA, Gannon FH, et al. Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type. Gene Ther 2003;10:1289-96 (Pubitemid 36987119)
70. Viggeswarapu M, Boden SD, Liu Y, et al. Adenoviral delivery of LIM mineralization protein-1 induces new-bone formation in vitro and in vivo. J Bone Joint Surg Am 2001;83-A:364-76 (Pubitemid 32221566)
71. Jang BJ, Byeon YE, Lim JH, et al. Implantation of canine umbilical cord blood-derived mesenchymal stem cells mixed with beta-tricalcium phosphate enhances osteogenesis in bone defect model dogs. J Vet Sci 2008;9:387-93
72. Chim H, Schantz JT. Human circulating peripheral blood mononuclear cells for calvarial bone tissue engineering. Plast Reconstr Surg 2006;117:468-78 (Pubitemid 44400633)
73. Labat ML. Stem cells and the promise of eternal youth: embryonic versus adult stem cells. Biomed Pharmacother 2001;55:179-85 (Pubitemid 32429563)
74. Arinzeh TL, Peter SJ, Archambault MP, et al. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental daefect. J Bone Joint Surg Am 2003;85-A:1927-35 (Pubitemid 37259728)
75. Hernigou P, Poignard A, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am 2005;87:1430-7 (Pubitemid 40917741)
76. Moutsatsos IK, Turgeman G, Zhou S, et al. Exogenously regulated stem cell mediated gene therapy for bone regeneration. Mol Ther 2001;3:449-61 (Pubitemid 32509838)
77. Nair MB, Varma HK, John A. Platelet-rich plasma and fibrin glue-coated bioactive ceramics enhance growth and differentiation of goat bone marrowr-derived stem cells. Tissue Eng Part A 2009;15:1619-31
78. Gimble J, Guilak F. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy 2003;5:362-9 (Pubitemid 37369023)
79. Kuroda R, Usas A, Kubo S, et al. Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum 2006;54:433-42 (Pubitemid 43228617)
80. Ducy P, Schinke T, Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 2000;289:1501-4
81. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-72 (Pubitemid 350138099)
82. Kao CL, Tai LK, Chiou SH, et al. Resveratrol promotes osteogenic differentiation and protects against dexamethasone damage in murine induced pluripotent stem cells. Stem Cells Dev 2010;19:247-58
83. Teichler Zallen D. US gene therapy in crisis. Trends Genet 2000;16:272-5
84. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003;302:415-19 (Pubitemid 37296260)
85. Schmidt-Wolf GD, Schmidt-Wolf IG. Non-viral and hybrid vectors in human gene therapy: an update. Trends Mol Med 2003;9:67-72 (Pubitemid 36313867)
86. Aslan H, Zilberman Y, Kandel L, et al. Osteogenic differentiation of noncultured immunoisolated bone marrow-derivedCD105+ cells. Stem Cells 2006; 024:1728-37 (Pubitemid 44474186)
87. Noel D, Gazit D, Bouquet C, et al. Short-term BMP-2 expression is sufficient for in vivo osteochondral differentiation of mesenchymal stem cells. Stem Cells 2004;22:74-85 (Pubitemid 38018783)
88. Wang Y, Huso DL, Harrington J, et al. Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. Cytotherapy 2005;7:509-19 (Pubitemid 43078081)
89. Nair V. Retrovirus-induced oncogenesis and safety of retroviral vectors. Curr Opin Mol Ther 2008;10:431-8
90. Schuldiner M, Itskovitz-Eldor J, Benvenisty N. Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells 2003;21:257-65 (Pubitemid 36623167)
91. Choo AB, Tan HL, Ang SN, et al. Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxiny-like protein-1. Stem Cells 2008;26:1454-63
92. Retzepi M, Donos N. Guided Bone Regeneration: biological principle and therapeutic applications. Clin Oral Implants Res 2010;21:567-76
93. Ohnishi H, Fujii N, Futami T, et al. A histochemical investigation of the bone formation process by guided bone regeneration in rat jaws. Effect of PTFE membrane application periods on newly formed bone. J Periodontol 2000;71:341-52
94. Fotek PD, Neiva RF, Wang HL. Comparison of dermal matrix and polytetrafluoroethylene membrane for socket bone augmentation: a clinical and histologic study. J Periodontol 2009;80:776-85
95. Evans CH, Ghivizzani SC, Robbins PD. Getting arthritis gene therapy into the clinic. Nat Rev Rheumatol 2011;7:244-9
96. Mease PJ, Wei N, Fudman EJ, et al. Safety, tolerability, and clinical outcomes after intraarticular injection of arecombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a Phase I/II Study. J Rheumatol 2010;37:692-703
97. Wehling P, Reinecke J, Baltzer AW, et al. Clinical responses to gene therapy in joints of two subjects with rheumatoid arthritis. Hum Gene Ther 2009;20:97-101
98. Chang PC, Cirelli JA, Jin Q, et al. Adenovirus encoding human platelet-derived growth factor-B delivered to alveolar bone defects exhibits safety and biodistribution profiles favorable for clinical use. Hum Gene Ther 2009;20:486-96